Title: Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation.
Authors: Hein, David W; Zhang, Xiaoyan; Doll, Mark A
Published In Toxicol Lett, (2018 Feb)
Abstract: Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) catalyze the acetylation of arylamine carcinogens. Single nucleotide polymorphisms in the NAT2 coding exon present in NAT2 haplotypes encode allozymes with reduced N-acetyltransferase activity towards the N-acetylation of arylamine carcinogens and the O-acetylation of their N-hydroxylated metabolites. NAT2 acetylator phenotype modifies urinary bladder cancer risk following exposures to arylamine carcinogens such as 4-aminobiphenyl. 4, 4'-methylene bis (2-chloroaniline) (MOCA) is a Group 1 carcinogen for which a role of the NAT2 acetylation polymorphism on cancer risk is unknown. We investigated the role of NAT2 and the genetic acetylation polymorphism on both MOCA N-acetylation and N-hydroxy-MOCA O-acetylation. MOCA N-acetylation exhibited a robust gene dose response in rabbit liver cytosol and in cryopreserved human hepatocytes derived from individuals of rapid, intermediate and slow acetylator NAT2 genotype. MOCA exhibited about 4-fold higher affinity for recombinant human NAT2 than NAT1. Recombinant human NAT2*4 (reference) and 15 variant recombinant human NAT2 allozymes catalyzed both the N-acetylation of MOCA and the O-acetylation of N-hydroxy-MOCA. Human NAT2 5, NAT2 6, NAT2 7 and NAT2 14 allozymes catalyzed MOCA N-acetylation and N-hydroxy-O-acetylation at rates much lower than the reference NAT2 4 allozyme. In conclusion, our results show that NAT2 acetylator genotype has an important role in MOCA metabolism and suggest that risk assessments related to MOCA exposures consider accounting for NAT2 acetylator phenotype in the analysis.
PubMed ID: 29180287
MeSH Terms: Acetylation; Animals; Arylamine N-Acetyltransferase/genetics*; Arylamine N-Acetyltransferase/metabolism*; Biotransformation; Carcinogens/metabolism*; Cytosol/metabolism; Hepatocytes/enzymology; Hepatocytes/metabolism; Humans; Isoenzymes/genetics; Isoenzymes/metabolism; Methylenebis(chloroaniline)/metabolism*; Polymorphism, Genetic; Rabbits; Recombinant Proteins; Urinary Bladder Neoplasms/chemically induced; Urinary Bladder Neoplasms/genetics; Urinary Bladder Neoplasms/pathology